喉癌诊断后戒烟可预测治疗反应及免喉切除术生存
回顾性病例对照研究纳入140例诊断时为当前吸烟者的喉鳞状细胞癌患者,均接受一线根治性放疗或放化疗。治疗前戒烟61例(45%),其完全缓解 odds 为持续吸烟者的3.7倍,7年内需挽救性喉切除术风险降低54%,7年总生存显著提高。
要点
- 诊断后治疗前戒烟与一线治疗完全缓解率显著提高相关(OR 3.694)。
- 戒烟者7年内需挽救性喉切除术风险较持续吸烟者降低54%(HR 0.456)。
- 戒烟者7年总生存较持续吸烟者显著提高(P = .02)。
核心结论
- 在诊断时为当前吸烟者的新诊断喉癌患者中,戒烟显著提高治疗反应、免喉切除术生存及总生存。
研究设计与样本
- 回顾性病例对照研究,纳入140例诊断时为当前吸烟者并接受一线根治性放疗或放化疗的喉鳞状细胞癌患者。
主要发现
- 140例当前吸烟者中61例(45%)在治疗开始前戒烟。
- 调整后logistic回归分析中,戒烟者一线治疗完全缓解的 odds 为持续吸烟者的3.7倍(OR 3.694 [1.575-8.661];P = .003)。
- 调整后Cox比例风险模型中,戒烟者诊断后7年内需挽救性喉切除术的可能性较持续吸烟者降低54%(HR 0.456 [0.246-0.848];P = .013)。
- 戒烟者7年总生存较持续吸烟者显著提高(P = .02)。
临床怎么用
- 作者认为应将戒烟项目系统地纳入喉癌治疗方案。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To determine the effect of tobacco cessation following laryngeal cancer diagnosis on response to first-line therapy, laryngectomy-free survival, and overall survival in patients who were current smokers at the time of diagnosis. STUDY DESIGN: Retrospective, case-control study. SETTING: OU Stephenson Cancer Center, National Cancer Institute-Designated Cancer Center. METHODS: We included 140 patients diagnosed with laryngeal squamous cell carcinoma, who were current smokers at the time of diagnosis, and were treated with first-line definitive radiation or chemo/radiation with the intent to cure. The association between patient characteristics and treatment response was assessed using the χ2 test and logistic regression analysis. Survival outcomes were analyzed using Kaplan-Meier methods and Cox proportional-hazards models. RESULTS: Of the 140 current smokers, 61 patients (45%) quit smoking prior to treatment initiation. In adjusted logistic regression analysis, quitters had 3.7 times higher odds of achieving a complete response to first-line therapy than active smokers (odds ratio: 3.694 [1.575-8.661]; P = .003). In the adjusted Cox proportional-hazards model, quitters were 54% less likely to require salvage laryngectomy within 7 years of diagnosis than active smokers (hazard ratio: 0.456 [0.246-0.848]; P = .013). Quitters had a statistically significant increase in 7-year overall survival compared to active smokers (P = .02). CONCLUSION: This is the first study to show that in newly diagnosed laryngeal cancer patients who are current smokers at the time of diagnosis, tobacco cessation significantly increases therapy response, laryngectomy-free survival, and overall survival. These data stress the importance of systematically incorporating tobacco cessation programs into laryngeal cancer treatment plans.
引用
- Krutz M, Acharya P, Elliott J, et al. Tobacco Cessation Following Laryngeal Cancer Diagnosis Predicts Response to Treatment and Laryngectomy-Free Survival. Otolaryngol Head Neck Surg. 2023. PMID: 37890055. doi:10.1002/ohn.567
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。